NCT06368401 - A First in Human Study for the Versa Device for Tricuspid Regurgitation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

October 2, 2025

Conditions

Tricuspid Regurgitation

Interventions

DEVICE

Versa Implant

The Versa Vascular Implant and Delivery System consists of a percutaneously delivered, permanent right-atrial implant and the delivery catheter that is used to first position the implant over the native valve orifice and to then place the implant.

Trial Locations (2)

Unknown

Pontificia Universidad Católica, Santiago

Auckland City Hospital, Auckland

All Listed Sponsors

collaborator

Cardiovascular Research Foundation, New York

OTHER

lead

Versa Vascular, Inc

INDUSTRY